Akums Drugs & Pharmaceuticals
AKUMS · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 6, 2024

Stock Price vs Company Growth
1d
3.5%
1w
2.5%
1m
4.2%
3m
10.7%
6m
6.1%
1y
5.2%
all
25.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 494 3.5%
410
515
Company Overview

Sales
4,257 Cr
Growth: 0.2%
Profit after Tax
310 Cr
Growth: 1.9%
Mid Cap
7,781 Cr
P/E: 23.8x
Industry P/E: 27.1x
Fundamentals

Sales (Cr) ₹ 4,257
Growth 0.2%
EBITDA 10.9%
P/S 1.8x
Dividend 0.0%
P/E 23.8x
Book Value ₹ 204
PEG Ratio 131.8x
ROE 9.9%
P/B 2.4x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

As a CDMO, the company produces an extensive range of dosage forms including tablets, capsules, liquid orals, vials, ampoules, blow-filled seals, topical preparations, eye drops, dry powder injections, and gummies, among others. It also engages in the marketing of trade generic and products under its own brand through distributors and alternative channels across India. Key Awards and accreditations2018: Received India Pharma Leader Award by Government of India.
Followers (2)